Back to the main directory
EarningsReview / Equity
- Mad Dog 2: bp''s latest big cash driver comes onstream by BNP Paribas Exane
- Q1''23: Spring sunshine before the rain by BNP Paribas Exane
- US for EVer by BNP Paribas Exane
- Novo Nordisk - Homing in on 30% CER sales growth by Danske Bank Equity Research
- VA March data by BNP Paribas Exane
- Kaufman & Broad - Croissance exceptionnelle au T1 : Austerlitz en ligne de mire by MidCap Partners
- Wallix - En sensible accélération ! by MidCap Partners
- Ekinops - New Solid Start to the Year by MidCap Partners
- Riverstone Credit Opportunities Income - High yield on the energy transition by Edison Investment Research
- INVEST SECURITIES - PATRIMOINE&COMMERCE: Des fondamentaux relativement robustes confortant les ambitions de croissance - ACHAT, OC 19€ by Invest Securities
- INVEST SECURITIES - TOOSLA : La déception de 2022 devrait être corrigée au S1 2023 - ACHAT, OC 4,15€ (vs 6,48€) by Invest Securities
- Norcros - In-line update highlights undervalued entity by Edison Investment Research
- 中信建投（601066 CH/6066 HK） by HSBC
- 北京君正（300223 CH） by HSBC
- 宁波银行（002142 CH） by HSBC
- Bank of Ningbo (002142 CH) by HSBC
- Hexatronic - Quality name at a discount by Danske Bank Equity Research
- Kahoot! - Earning from learning by Danske Bank Equity Research
- Viaplay Group (Buy, TP: SEK390.00) - Strong ARPU growth story for H2e by DnB Markets
- Novo Nordisk (Buy, TP: DKK1330.00) - Another increase to our estimates by DnB Markets
- Kone (Hold, TP: EUR52.00) - Escalator up by DnB Markets
- Vår Energi (Buy, TP: NOK38.00) - Minor model adjustment by DnB Markets
- Weekly news, topics & discussion by DnB Markets
- Reinstated recommendation and start of Q1 reporting season by DnB Markets
- Beijer Ref (Hold, TP: SEK188.00) - US market compelling long-term by DnB Markets
- Taiwan Telcos by HSBC
- Q1:23 Previews: In Need of EPS Upgrades by BNP Paribas Exane
- Offshore outlook: still warming by BNP Paribas Exane
- Bang & Olufsen - Focus on cash flow is material, China by Danske Bank Equity Research
- Elanders - commissioned research: Margins overshadowed by accounting issue by Nordea
- Ekinops - Nouvelle solide entame d’exercice by MidCap Partners
- Wallix - A Noticeable Acceleration! by MidCap Partners
- Kaufman & Broad - Exceptional Q1 Growth: Austerlitz On Target by MidCap Partners
- Thrace Group - Demonstrable core growth as COVID-19 subsides by Edison Investment Research
- INVEST SECURITIES - BIOPHYTIS : Décision de la HAS attendue au T2 2023 pour BIO101 - NEUTRE, OC 0,21€ by Invest Securities
- EML Payments - Considering its options by Edison Investment Research
- LVMH - 1Q WELL ABOVE ESTIMATES AND CAUTIOUSLY OPTIMISTIC OUTLOOK by Equita Sim
- CSC Financial (601066 CH/6066 HK) by HSBC
- Kempower - Impressive delivery continues by Danske Bank Equity Research
- 兴业银行（601166 CH） by HSBC
- Industrial Bank (601166 CH) by HSBC
- Infosys Limited (INFO IN) by HSBC
- Areas of strength, but market remains challenging by BNP Paribas Exane
- Scatec (Sell, TP: NOK56.00) - Near-term positives by DnB Markets
- TGS (Buy, TP: NOK230.00) - Momentary weakness by DnB Markets
- Multiconsult (Buy, TP: NOK175.00) - Expecting a record order backlog by DnB Markets
- YIT (Hold, TP: EUR2.40) - No light in sight by DnB Markets
- Danske Bank (Buy, TP: DKK190.00) - Strong Q1 bodes well for upbeat 2023 by DnB Markets
- Valuation and market update by DnB Markets
- Genmab (Sell, TP: DKK2650.00) - Back-end loaded 2023e news flow by DnB Markets